You are here: Industry Insights > cancer

News List

Combination immunotherapy improves survival in mouse models of mesothelioma europeanpharmaceuticalreview
April 28, 2019
Combined treatment with two cancer immunotherapy drugs significantly prolonged survival in aggressive cancer malignant mesothelioma…
Contrast-enhanced subharmonic imaging detects prostate cancers europeanpharmaceuticalreview
April 25, 2019
A test of contrast-enhanced subharmonic imaging has shown promise in detecting prostate cancers that were not identified by MRI…
Delivering cancer treatment on a nanodisc helps eliminate tumours europeanpharmaceuticalreview
April 25, 2019
Novel platform for chemo-immunotherapy eliminated colon cancer in 85 percent of treated mice…
Blood test predicts effectiveness of palbociclib in breast cancer patients europeanpharmaceuticalreview
April 25, 2019
A new study has found a blood test for cancer DNA could predict if a woman is responding to the new breast cancer drug palbociclib, months earlier than current tests…
RNA-based therapy cures lung cancer europeanpharmaceuticalreview
April 25, 2019
By turning down the activity of a specific RNA molecule, researchers have cured lung tumours in mice…
CDC Provides Clarification of Opioid Prescribing Guideline drugs
April 25, 2019
CDC Provides Clarification of Opioid Prescribing Guideline
Cancer Research UK, Ono and LifeArc to identify new cancer drugs pharmaceutical-technology
April 24, 2019
Cancer Research UK (CRUK) has partnered with Japanese drugmaker Ono Pharmaceutical and not-for-profit LifeArc to identify new immunotherapy drug targets for cancer.
Personalizing precision medicine with combination therapies improves outcomes in cancer worldpharmanews
April 24, 2019
Precision oncology often relies on treating patients with a single, molecularly matched therapy that targets one mutation in their tumor.
Merck’s Keytruda gets FDA approval to treat kidney cancer pharmaceutical-technology
April 24, 2019
Merck has received US Food and Drug Administration (FDA) approval for its anti-PD-1 therapy Keytruda to treat advanced renal cell carcinoma (RCC) patients.
MDxHealth's SelectMDx Test Successfully Stratifies Men Who May Benefit from mp-MRI for Prostate Cancer Diagnosis b3cnewswire
April 23, 2019
MDxHealth's SelectMDx Test Successfully Stratifies Men Who May Benefit from mp-MRI for Prostate Cancer Diagnosis.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 88 89 Next page